PMID- 27260368 OWN - NLM STAT- MEDLINE DCOM- 20170406 LR - 20170406 IS - 1532-8511 (Electronic) IS - 1052-3057 (Linking) VI - 25 IP - 8 DP - 2016 Aug TI - Association of Hyperhomocysteinemia with Stroke Recurrence after Initial Stroke. PG - 2047-54 LID - S1052-3057(16)30063-5 [pii] LID - 10.1016/j.jstrokecerebrovasdis.2016.05.008 [doi] AB - BACKGROUND AND PURPOSE: Homocysteine (Hcy) is closely associated with stroke. Despite the fact that Hcy has consistently been shown to predict development of recurrent stroke, prior studies on the association of Hcy and stroke subtypes have been inconclusive. METHODS: Data from the Ege Stroke Registry were examined and 5-year follow-up data were analyzed. Multivariate survival analyses were undertaken using Cox proportional hazards models to determine the prognostic value of Hcy in different ischemic stroke subtypes. RESULTS: Of the 9522 patients with stroke, 307 (27%) with hyperhomocysteinemia (hHcy) had recurrent stroke. Univariate Cox regression model showed that hHcy group was associated with recurrent stroke (crude hazard ratio [HR] 1.16; 95% CI 1.02-1.30). But there was no such association in multivariate regression models (adjusted HR 1.11; 95% CI .97-1.26). hHcy was not associated with any ischemic stroke subtypes at 5 years. Univariate Cox regression model showed that hHcy group was associated with overall cardiovascular events (crude HR 1.44; 95% CI 1.32-1.57). However, this association no longer existed in multivariate regression models (adjusted HR 1.01; 95% CI .93-1.12). Higher plasma Hcy group was significantly associated with higher mortality compared with normal plasma Hcy group (OR 1.83; 95% CI .45-2.32). CONCLUSIONS: Our results showed that elevated Hcy is not associated independently with stroke recurrence and overall cardiovascular events in patients with ischemic stroke. There was no association between the hHcy and stroke recurrence in the stroke subtypes within 5 years. CI - Copyright (c) 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved. FAU - Kumral, Emre AU - Kumral E AD - Stroke Unit, Neurology Department, School of Medicine, Ege University, Izmir, Turkey. Electronic address: emre.kumral@ege.edu.tr. FAU - Saruhan, Gulsum AU - Saruhan G AD - Stroke Unit, Neurology Department, School of Medicine, Ege University, Izmir, Turkey. FAU - Aktert, Dilara AU - Aktert D AD - Stroke Unit, Neurology Department, School of Medicine, Ege University, Izmir, Turkey. FAU - Orman, Mehmet AU - Orman M AD - Biostatistic Department, School of Medicine, Ege University, Izmir, Turkey. LA - eng PT - Journal Article DEP - 20160531 PL - United States TA - J Stroke Cerebrovasc Dis JT - Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association JID - 9111633 RN - 12001-76-2 (Vitamin B Complex) RN - 462-10-2 (Homocystine) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Electrocardiography MH - Female MH - Homocystine/blood MH - Humans MH - Hyperhomocysteinemia/*complications/diagnostic imaging/*epidemiology MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Neuroimaging MH - Proportional Hazards Models MH - Recurrence MH - Risk Factors MH - Statistics, Nonparametric MH - Stroke/blood/*complications/diagnostic imaging/*epidemiology MH - Survival Analysis MH - Vitamin B Complex/therapeutic use OTO - NOTNLM OT - Homocysteine OT - large-artery disease OT - small-artery disease OT - stroke recurrence EDAT- 2016/06/05 06:00 MHDA- 2017/04/07 06:00 CRDT- 2016/06/05 06:00 PHST- 2016/04/18 00:00 [received] PHST- 2016/05/06 00:00 [revised] PHST- 2016/05/08 00:00 [accepted] PHST- 2016/06/05 06:00 [entrez] PHST- 2016/06/05 06:00 [pubmed] PHST- 2017/04/07 06:00 [medline] AID - S1052-3057(16)30063-5 [pii] AID - 10.1016/j.jstrokecerebrovasdis.2016.05.008 [doi] PST - ppublish SO - J Stroke Cerebrovasc Dis. 2016 Aug;25(8):2047-54. doi: 10.1016/j.jstrokecerebrovasdis.2016.05.008. Epub 2016 May 31.